These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia. Ataergin S, Arpaci F, Cetin T, Guran S, Yakicier C, Beyzadeoglu M, Ozet A. Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734 [Abstract] [Full Text] [Related]
5. [Donor leukocyte transfusion in a patient with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation: analysis of natural killer cell activity and T-cell receptor repertoire in bone marrow T cells that exhibited graft-versus-leukemia activity]. Suehiro Y, Muta K, Umemura T, Motomura S, Nishimura J, Nawata H, Kimura N. Rinsho Ketsueki; 1999 Jan; 40(1):40-5. PubMed ID: 10067095 [Abstract] [Full Text] [Related]
7. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse. Wysoczanska B, Bogunia-Kubik K, Dlubek D, Jaskula E, Sok A, Drabczak-Skrzypek D, Sedzimirska M, Lange A. Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011 [Abstract] [Full Text] [Related]
9. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Saito Y, Uzuka Y, Sakai N, Suzuki S, Toyota T. Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535 [Abstract] [Full Text] [Related]
10. Monitoring of T-cell repertoire was useful for predicting graft-versus-host disease prognosis in a patient with chronic myelogeneous leukemia after allogeneic bone marrow transplantation. Tsutsumi Y, Tanaka J, Minami H, Musashi M, Fukushima A, Kawamura T, Kanamori H, Obara S, Noto S, Ogura N, Asaka M, Imamura M, Masauzi N. Transplant Proc; 2004 Dec; 36(10):3200-2. PubMed ID: 15686728 [Abstract] [Full Text] [Related]
11. Gammadelta T-cell large granular lymphocyte (LGL) leukemia with spontaneous remission. Shichishima T, Kawaguchi M, Ono N, Oshimi K, Nakamura N, Maruyama Y. Am J Hematol; 2004 Mar; 75(3):168-72. PubMed ID: 14978699 [Abstract] [Full Text] [Related]
12. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation. Li JM, Waller EK. Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532 [Abstract] [Full Text] [Related]
13. Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population. Maury S, Belhadj K, Chami I, Kuentz M, Cordonnier C, Bories D. Bone Marrow Transplant; 2001 Oct; 28(7):717-20. PubMed ID: 11704798 [Abstract] [Full Text] [Related]
14. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature. Reichard KK, Zhang QY, Sanchez L, Hozier J, Viswanatha D, Foucar K. Am J Hematol; 2006 Mar; 81(3):178-85. PubMed ID: 16493618 [Abstract] [Full Text] [Related]
20. T-cell prolymphocytic leukemia in a 63-year-old female with a pre-existing T-cell large granular lymphocytic leukemia: metachronous T-cell leukemias with discordant subset restrictions (CD4 versus CD8) and distinct clonal identities. Wei Q, Papavassiliou P, Rehder C, Sebastian S, Wang E. Pathol Res Pract; 2014 Dec; 210(12):1100-5. PubMed ID: 25238936 [Abstract] [Full Text] [Related] Page: [Next] [New Search]